Results 11 to 20 of about 378,540 (249)

The Vasculopathy of Juvenile Dermatomyositis [PDF]

Frontiers in Pediatrics, 2018
Juvenile dermatomyositis (JDM) is a rare autoimmune disease mainly characterized by muscle and skin involvement. Vasculopathy is considered central to the pathogenesis of the disease.
Charalampia Papadopoulou, Papadopoulou Charalampia, Mccann Liza J   +2 more
exaly   +6 more sources

Dyslipidemia in Juvenile Dermatomyositis [PDF]

Scientific Reports
This study investigates the prevalence of dyslipidemia and its association with disease activity in children with Juvenile Dermatomyositis (JDM). A retrospective chart review of 142 JDM patients who had fasting lipid profiles was conducted. Clinical, and
Amer Khojah, Gabrielle Morgan, Arya Kadakia, Marisa S. Klein-Gitelman, Lauren M. Pachman   +4 more
doaj   +4 more sources

Juvenile Dermatomyositis

Journal of Rheumatic Diseases, 2022
Juvenile dermatomyositis (JDM) is a systemic capillary vasculopathy. Patients present with proximal muscle weakness, raised muscle enzymes, and pathognomic skin rashes such as heliotrope rash, Gottron’s papules.
Jung-Woo Rhim
semanticscholar   +5 more sources

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment

Frontiers in Medicine, 2023
Calcinosis, or the deposition of insoluble calcium salts in the skin, subcutaneous tissue, fascia, tendons, and muscles, is a feared complication of juvenile dermatomyositis.
Caitlan S. Pinotti, Laura Cannon, Jeffrey A. Dvergsten, Eveline Y. Wu, Eveline Y. Wu   +4 more
doaj   +2 more sources

B Cell Lymphocytosis in Juvenile Dermatomyositis

Diagnostics, 2023
In this study, we determined if B lymphocytosis may serve as a JDM biomarker for disease activity. Children with untreated JDM were divided into two groups based on age-adjusted B cell percentage (determined through flow cytometry): 90 JDM in the normal ...
Lauren Pachman, Saravanan S, Amer Khojah   +2 more
exaly   +2 more sources

A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis

The Turkish Journal of Pediatrics, 2021
Background. Juvenile dermatomyositis associated interstitial lung disease, rarely seen in pediatric age groups, has adverse effects on survival.
Osman Yeşilbaş, Kenan Barut, Sezgin Şahin, Amra Adrovic, Erkan Çakır, Hakan Yazan, Irmak Tahaoğlu, Can Yılmaz Yozgat, Mehmet Yıldız, Özgür Kasapçopur   +9 more
doaj   +2 more sources

JUVENILE DERMATOMYOSITIS [PDF]

Romanian Journal of Pediatrics, 2016
Juvenile dermatomyositis is a severe multisystemic autoimmune disease of uncertain origin, based on chronic perivascular inflammation, involving mainly the skin and the muscles.
Sigrid Covaci, Oana-Maria Farkas, Alexis-Virgil Cochino   +2 more
doaj   +3 more sources

Juvenile Dermatomyositis in Pregnancy

Case Reports in Obstetrics and Gynecology, 2013
Juvenile dermatomyositis has variable clinical presentations both in and outside of pregnancy. A literature review indicated that optimal maternal and fetal outcomes can be anticipated when the pregnancy is undertaken while the disease is in remission ...
Anthony Emeka Madu, Edwin Omih, Elaine Baguley, Stephen W. Lindow   +3 more
doaj   +3 more sources

Anasarca as the presenting symptom of juvenile dermatomyositis: a case series

Pediatric Rheumatology Online Journal, 2021
Background Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refractory course,
Emily E. Schildt, Deirdre De Ranieri
doaj   +2 more sources

Untargeted metabolomics reveals serum metabolites related to energy metabolism and inflammation associated with juvenile dermatomyositis. [PDF]

Metabolomics
Kirkwood-Donelson KI, Johnson DJ, Farhadi PN, Sarkar K, Schiffenbauer AI, Miller FW, Kudzin G, Baker ES, Li JL, Rider LG, Jarmusch AK.   +10 more
europepmc   +4 more sources